Pratchett and Assisted Dying: A Question of Balance?

If you’ve not yet seen “Choosing to Die”, Terry Pratchett’s film about Dignitas from Monday night, I recommend that you go and watch it now.  (I don’t know if it’s available outside the UK: I’m sure it’ll appear on YouTube soon, though; or, if you’re outside th UK, get a Brit to download it and […]

Read More…

Couldn’t find the language – the positive counterparts of risk and hazards

Continuing my recent theme of the impact of language on ethics and decision making I’m presently writing a paper on the use of claims based on justice to object to new technologies such as human enhancement or synthetic biology. In the process of writing this paper I’ve encountered a rather odd gap in our language. […]

Read More…

Stem-Cells: To Patent or Not?

In spare moments, I’ve been wondering about the Advocate-General of European Court of Justice’s recent recommendation that patents involving human embryonic stem-cells be prohibited, and the response that it’s generated.  One of the best-publicised responses was the letter from Austin Smith et al that appeared in Nature, which complained that the recommendation would be bad […]

Read More…

Hyperexpensive royal weddings – the opportunity costs in terms of health

James Wilson (UCL) and I recently wrote a briefing paper for the Nuffield Council on Bioethics on the ethical issues surrounding hyper-expensive treatments – that is treatments which exceed NICEs usual cut off point of £30000 per quality adjusted life year (qualy). One factor that we kept coming back to was the need to consider […]

Read More…